UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $24.36 Million Holdings in Inspire Medical Systems, Inc. $INSP

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 21.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 546,020 shares of the company’s stock after buying an additional 97,233 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Inspire Medical Systems were worth $24,358,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of INSP. CWM LLC boosted its stake in Inspire Medical Systems by 216.1% during the 4th quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after acquiring an additional 242 shares during the last quarter. Havemeyer Place LP acquired a new stake in Inspire Medical Systems in the fourth quarter worth $39,000. Smartleaf Asset Management LLC boosted its position in shares of Inspire Medical Systems by 84.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock worth $42,000 after purchasing an additional 205 shares in the last quarter. Daiwa Securities Group Inc. increased its position in shares of Inspire Medical Systems by 38.7% in the 2nd quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock valued at $60,000 after buying an additional 130 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Inspire Medical Systems by 1,115.4% during the first quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company’s stock worth $33,000 after purchasing an additional 580 shares during the period. 94.91% of the stock is owned by institutional investors.

Inspire Medical Systems Stock Performance

NYSE INSP opened at $62.99 on Friday. Inspire Medical Systems, Inc. has a 52 week low of $38.91 and a 52 week high of $147.03. The stock’s 50 day moving average price is $55.05 and its two-hundred day moving average price is $52.43. The stock has a market capitalization of $1.82 billion, a price-to-earnings ratio of 13.63, a PEG ratio of 4.72 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of ($0.24) by $0.38. The company had revenue of $200.58 million during the quarter, compared to analysts’ expectations of $194.72 million. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The business’s quarterly revenue was down 7.6% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, equities research analysts forecast that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Analysts Set New Price Targets

INSP has been the topic of a number of research reports. Freedom Capital raised shares of Inspire Medical Systems to a “strong-buy” rating in a research note on Tuesday, June 30th. Royal Bank Of Canada reissued a “sector perform” rating and set a $60.00 price objective on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Bank of America lowered shares of Inspire Medical Systems from a “neutral” rating to an “underperform” rating and set a $39.00 price objective on the stock. in a report on Friday, May 22nd. Weiss Ratings raised shares of Inspire Medical Systems from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, August 19th. Finally, Summit Redstone set a $39.00 target price on Inspire Medical Systems in a report on Friday, May 22nd. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, Inspire Medical Systems presently has an average rating of “Hold” and an average price target of $66.19.

Insiders Place Their Bets

In other Inspire Medical Systems news, insider Jason Kelly sold 963 shares of Inspire Medical Systems stock in a transaction on Friday, August 7th. The shares were sold at an average price of $59.55, for a total value of $57,346.65. Following the sale, the insider directly owned 18,985 shares in the company, valued at approximately $1,130,556.75. The trade was a 4.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.20% of the company’s stock.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.